Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
Abstract
BACKGROUND: The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS: Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS: A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS: The novel coronavirus might have a role in causing SARS.
Overview
CoChat Summary
## TL;DR
The paper identifies a previously unknown coronavirus in patients with severe acute respiratory syndrome (SARS) and provides PCR and serologic evidence linking it to the illness. It also reports that viral RNA was found at very high levels in sputum, with lower-level detection in plasma and later in stool, supporting a respiratory infection with possible additional shedding routes.
## Key findings
- A novel coronavirus was isolated from sputum of the index patient after 6 days of incubation in Vero-cell culture, and a 300-nucleotide sequence was obtained by random RT-PCR.
- Genetic analysis found the virus was only distantly related to known coronaviruses, with the BNI-1 sequence differing by 39% to 46% from known sequences and by 50% to 60% identical nucleotide sequence to known coronaviruses.
- In the Hanoi outbreak panel, the virus was detected in 100% of patients with probable SARS, 23% of those with suspected SARS, and 0% of healthy contacts.
- Quantitative PCR found viral RNA concentrations of up to 100 million molecules per milliliter in sputum; the index patient also had RNA in plasma at 190 (day 9) and stool on day 25, and Contact 1 had 6.3 × 10^4 in sputum and 4.1 × 10^5 in BAL.
## Methods
- Clinical specimens from SARS patients were screened for known and unknown pathogens using cell culture, electron microscopy, PCR, antigen ELISA, serology, and sequence/phylogenetic analysis.
- The study examined specimens from 3 patients in Frankfurt (index patient, Contact 1, Contact 2) and a panel of 49 specimens from 18 suspected/probable SARS patients and 21 healthy contacts in Hanoi, plus 54 stool controls from Germany.
- A random RT-PCR approach and subsequent nested and real-time RT-PCR assays were developed to identify and quantify the novel virus, with specificity tested against several other coronaviruses.
## Limitations
- The paper itself states that larger studies with appropriate control groups are needed to verify or reject the hypothesis that this virus causes SARS.
- The authors note that the antibody response might not be definitively directed against the novel coronavirus, because the antigen used in serology came from primary cultures; they say this should be tested with plaque-purified virus or recombinant proteins.
- Evidence of causation is not established here; the paper shows association and detection in patients, but the conclusion is only that the virus “might have a role” in causing SARS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 7 Not checked · 67 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The presence of viral RNA in stool of the patients late during convalescence is reminiscent of characteristics of other coronaviruses. 13”
What the sources say
- Partly supportedcites [13] matched to “Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle” (2001) sourceExperimental — accuracy not yet measured
Our copy of Cho et al (2001) supports only the general point that a bovine coronavirus is present/shed in feces: fecal samples from 56 feedlot steers were positive for BCV by antigen-capture ELISA and virus isolation (Results, p. 1; Materials and Methods, Sample Collections), and the Discussion (p. 6) notes 22% of fecal samples from cattle without diarrhea were antigen-positive, suggesting they 'had diarrhea during shipping or at the auction barn and were still shedding BCV'. The specific elements the citing sentence attributes are absent: detection was of antigen/infectious virus, not viral RNA (no RT-PCR assay appears anywhere in our copy; RT-PCR of feces belongs to a work it cites, Tsunemitsu and Saif, ref 35), samples were taken only on days 0, 4, 14 and 21 after arrival rather than late during convalescence, in cattle rather than human patients, and the paper makes no comparative statement about shared characteristics of other coronaviruses. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Infected patients showed seroconversion on the Vero cells in which the virus was isolated.”
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About 20 distinct DNA fragments were obtained and sequenced.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three of the fragments did not match any nucleotide sequence in the data base.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“since there was serologic evidence of an acute infection with this virus in our index patient and also in Contact 1”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 75 claims and to verify the 7 references still open.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 11
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768
Drosten, C., Göttig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., & Günther, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2323-2330.2002 · Cited by 631
Self-citationImported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000504 · Cited by 200
Self-citationStephensen, C. B., Casebolt, D. B., & Gangopadhyay, N. N. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00017-9 · Cited by 135
Cho, K.-O., Hoet, A. E., Loerch, S. C., Wittum, T. E., & Saif, L. J. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1436 · Cited by 88
TTV a common virus, but pathogenic?
Cossart, Y. E. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77802-8 · Cited by 44
HGV: hepatitis G virus or harmless G virus?
Kew, M. C., & Kassianides, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98020-4 · Cited by 39
Research works printed but not linked: 2
- 2003, Wkly Epidemiol Rec, 78, 81
- 2003, Wkly Epidemiol Rec, 78, 73
Cited by
Items 801–900 of 1,020
RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target
Wang, Y., Anirudhan, V., Du, R., Cui, Q., & Rong, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26264 · Cited by 115
Pathogenesis of Murine Coronavirus in the Central Nervous System
Bender, S. J., & Weiss, S. R. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9202-2 · Cited by 117
Characterization of viral proteins encoded by the SARS-coronavirus genome
Tan, Y., Lim, S. G., & Hong, W. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.10.001 · Cited by 118
Processing of the SARS-CoV pp1a/ab nsp7–10 region
Krichel, B., Falke, S., Hilgenfeld, R., Redecke, L., & Uetrecht, C. (2020) · Biochemical Journal · doi:10.1042/bcj20200029 · Cited by 116
Alquisiras-Burgos, I., Peralta-Arrieta, I., Alonso-Palomares, L. A., Zacapala-Gómez, A. E., Salmerón-Bárcenas, E. G., & Aguilera, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02134-7 · Cited by 115
Yang, L.-T., Peng, H., Zhu, Z.-L., Li, G., Huang, Z.-T., Zhao, Z.-X., Koup, R. A., Bailer, R. T., & Wu, C.-Y. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.05.002 · Cited by 117
Poon, L. L. M., Leung, C. S.-W., Tashiro, M., Chan, K. H., Wong, B. W. Y., Yuen, K., Guan, Y., & Peiris, J. S. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032011 · Cited by 117
Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus
Timani, K. A., Liao, Q., Ye, L., Zeng, Y., Liu, J., Zheng, Y., Ye, L., Yang, X., Ling-bao, K., Gao, J., et al. (2005) · Virus Research · doi:10.1016/j.virusres.2005.05.007 · Cited by 115
Children Hospitalized With Severe Acute Respiratory Syndrome-Related Illness in Toronto
Bitnun, A., Allen, U., Heurter, H., King, S., Opavsky, M. A., Ford-Jones, E. L., Matlow, A., Kitai, I., Tellier, R., Richardson, S. E., et al. (2003) · PEDIATRICS · doi:10.1542/peds.112.4.e261 · Cited by 115
Hamouda, M. A., Mustafa, F., Maraqa, M. A., Rizvi, T. A., & Hassan, A. A. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143493 · Cited by 127
A Review on SERS-Based Detection of Human Virus Infections: Influenza and Coronavirus
Saviñon-Flores, F., Méndez, E., López-Castaños, M., Carabarín‐Lima, A., López-Castaños, K. A., González‐Fuentes, M. A., & Méndez‐Albores, A. (2021) · Biosensors · doi:10.3390/bios11030066 · Cited by 121
A human SARS-CoV neutralizing antibody against epitope on S2 protein
Duan, J., Yan, X., Guo, X., Cao, W., Han, W., Qi, C., Feng, J., Yang, D., Gao, G., & Jin, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.089 · Cited by 114
“The worldwide outbreak of severe acute respiratory syndrome (SARS) as a newly emerging disease caused by SARS-associated coronavirus (SARS-CoV) represents the most recent threat to human health [1] [2] [3] .”
SARS in Taiwan: an overview and lessons learned
Chen, K., Twu, S., Chang, H.-L., Wu, Y.-C., Chen, C.-T., Lin, T.-H., Olsen, S. J., Dowell, S. F., & Su, I. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.04.015 · Cited by 125
Proliferative growth of SARS coronavirus in Vero E6 cells
Ng, M.-L., Tan, S.-H., See, E.-E., Ooi, E.-E., & Ling, A.-E. (2003) · Journal of General Virology · doi:10.1099/vir.0.19505-0 · Cited by 114
He, Y., Wang, J., Li, F., & Shi, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01302 · Cited by 114
Expression, purification, and characterization of SARS coronavirus RNA polymerase
Cheng, A., Zhang, W., Xie, Y., Jiang, W., Arnold, E., Sarafianos, S. G., & Ding, J. (2005) · Virology · doi:10.1016/j.virol.2005.02.017 · Cited by 114
Hamano, E., Hijikata, M., Itoyama, S., Quy, T., Phi, N. C., Long, H. T., Ha, L. D., Ban, V. V., Matsushita, I., Yanai, H., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.101 · Cited by 117
Yuan, X., Wu, J., Shan, Y., Yao, Z., Dong, B., Chen, B., Zhao, Z., Wang, S., Chen, J., & Cong, Y. (2005) · Virology · doi:10.1016/j.virol.2005.10.015 · Cited by 124
Pathology of Experimental SARS Coronavirus Infection in Cats and Ferrets
van den Brand, J. M. A., Haagmans, B. L., Leijten, L. M. E., van Riel, D. A. J., Martina, B. E. E., Osterhaus, A. D. M. E., & Kuiken, T. (2008) · Veterinary Pathology · doi:10.1354/vp.45-4-551 · Cited by 131
Self-citationChan, K. H., Cheng, V. C. C., Woo, P. C. Y., Lau, S. K. P., Poon, L. L. M., Guan, Y., Seto, W. H., Yuen, K. Y., & Peiris, J. S. M. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.11.1317-1321.2005 · Cited by 113
Takasuka, N. (2004) · International Immunology · doi:10.1093/intimm/dxh143 · Cited by 114
Cheng, V. C. C., Hung, I. F. N., Tang, B. S. F., Chu, C. M., Wong, M. M. L., Chan, K. H., Wu, A. K. L., Tse, D. M. W., Chan, K. S., Zheng, B. J., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/382681 · Cited by 113
Kaul, D. (2020) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2020.04.001 · Cited by 116
Keil, S. D., Ragan, I. K., Yonemura, S., Hartson, L., Dart, N. K., & Bowen, R. A. (2020) · Vox Sanguinis · doi:10.1111/vox.12937 · Cited by 123
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
Lockbaum, G. J., Reyes, A. C., Lee, J. M., Tilvawala, R. R., Nalivaika, E. A., Ali, A., Yılmaz, N. K., Thompson, P. R., & Schiffer, C. A. (2021) · Viruses · doi:10.3390/v13020174 · Cited by 113
Severe acute respiratory syndrome: identification of the etiological agent
Drosten, C., Preiser, W., Günther, S., SCHMITZ, H. E., & Doerr, H. W. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00133-3 · Cited by 113
Self-citationSuppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein
Yuan, K., Yi, L., Chen, J., Qu, X., Qing, T., Rao, X., Jiang, P., Hu, J., Xiong, Z., Nie, Y., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.046 · Cited by 109
Dong, S., Sun, J., Mao, Z., Wang, L., Lu, Y.-L., & Li, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25768 · Cited by 122
Coley, S. E., Lavi, E., Sawicki, S. G., Fu, L., Schelle, B., Karl, N., Siddell, S. G., & Thiel, V. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.3097-3106.2005 · Cited by 119
The 2003 SARS outbreak and its impact on infection control practices
Shaw, K. (2005) · Public Health · doi:10.1016/j.puhe.2005.10.002 · Cited by 127
Greenough, T. C., Carville, A., Coderre, J. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., & Mansfield, K. G. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62989-6 · Cited by 117
Identification of new human coronaviruses
Pyrć, K., Berkhout, B., & van der Hoek, L. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.2.245 · Cited by 111
Xu, D., Zhang, Z., Jin, L., Chu, F., Mao, Y., Wang, H., Liu, M., Wang, M., Zhang, L., Gao, G. F., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1299-5 · Cited by 111
How much reduction of virus is needed for recycled water: A continuous changing need for assessment?
Gerba, C. P., Betancourt, W. Q., & Kitajima, M. (2016) · Water Research · doi:10.1016/j.watres.2016.11.020 · Cited by 121
A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis
Ye, Z., Wong, C. K., Li, P., & Xie, Y. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.07.009 · Cited by 114
siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication
Li, T., Zhang, Y., Fu, L., Yu, C., Li, X. T., Li, Y., Zhang, X., Rong, Z., Wang, Y., Ning, H., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302479 · Cited by 111
COVID-19 challenges and its therapeutics
Rehman, S. U., Rehman, S. U., & Yoo, H. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112015 · Cited by 130
Wang, J., Pan, Y., Yang, L., Yang, W., Lv, K., Luo, C., Wang, J., Kuang, G., Wu, W.-C., Gou, Q., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39835-1 · Cited by 130
Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A
Luo, C., Luo, H., Zheng, S., Gui, C., Yue, L., Yu, C., Sun, T., He, P., Chen, J., Shen, J., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.003 · Cited by 111
Ritchie, G., Harvey, D. J., Feldmann, F., Stroeher, U., Feldmann, H., Royle, L., Dwek, R. A., & Rudd, P. M. (2010) · Virology · doi:10.1016/j.virol.2009.12.020 · Cited by 111
Dominguez, S. R., Robinson, C. C., & Holmes, K. V. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21541 · Cited by 109
SARS in Singapore – Predictors of Disease Severity
Leong, H.-N., Earnest, A., Lim, H.-H., Chin, C.-F., Tan, C. S., Puhaindran, M. E., Tan, A. C., Chen, M. I., & Leo, Y.-S. (2006) · Annals of the Academy of Medicine, Singapore · doi:10.47102/annals-acadmedsg.v35n5p326 · Cited by 110
Respiratory Infections in the U.S. Military: Recent Experience and Control
Sánchez, J. L., Cooper, M. J., Myers, C. A., Cummings, J. F., Vest, K. G., Russell, K. L., Sanchez, J. L., Hiser, M. J., & Gaydos, C. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00039-14 · Cited by 121
Effects of Coronavirus Infections in Children
Principi, N., Bosis, S., & Esposito, S. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1602.090469 · Cited by 109
Novel SARS-like Betacoronaviruses in Bats, China, 2011
Yang, L., Wu, Z., Ren, X., Yang, F., He, G., Zhang, J., Dong, J., Sun, L., Zhu, Y., Du, J., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1906.121648 · Cited by 111
Pathological Role of Angiotensin II in Severe COVID-19
Miesbach, W. (2020) · TH Open · doi:10.1055/s-0040-1713678 · Cited by 116
End-To-End Deep Learning Framework for Coronavirus (COVID-19) Detection and Monitoring
El-Rashidy, N. M., El–Sappagh, S., Islam, S. M. R., El-Bakry, H. M., & Abdelrazek, S. M. (2020) · Electronics · doi:10.3390/electronics9091439 · Cited by 117
Binding of the SARS-CoV-2 spike protein to glycans
Hao, W., Ma, B., Li, Z., Wang, X., Gao, X., Li, Y., Qin, B., Shang, S., Cui, S., & Tan, Z. (2021) · 中国科学通报:英文版 · doi:10.1016/j.scib.2021.01.010 · Cited by 118
Genome structure and transcriptional regulation of human coronavirus NL63
Pyrc, K., Jebbink, M. F., Berkhout, B., & van der Hoek, L. (2004) · Virology Journal · doi:10.1186/1743-422x-1-7 · Cited by 111
Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine
Zhao, P., Cao, J., Zhao, L.-J., Qin, Z.-L., Ke, J.-S., Pan, W., Ren, H., Yu, J.-G., & Qi, Z.-T. (2005) · Virology · doi:10.1016/j.virol.2004.10.016 · Cited by 111
SARS-associated Coronavirus Transmitted from Human to Pig
Chen, W., Yan, M., Yang, L., Ding, B., He, B., Wang, Y., Liu, X., Liu, C., Zhu, H., You, B., et al. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1103.040824 · Cited by 109
Vabret, A., Dina, J., Gouarin, S., Petitjean, J., Tripey, V., Brouard, J., & Freymuth, F. (2007) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2007.01246.x · Cited by 107
Hu, T., Zhang, Y. L., Li, L., Wang, K., Chen, S., Chen, J., Ding, J., Jiang, H., & Shen, X. (2009) · Virology · doi:10.1016/j.virol.2009.03.034 · Cited by 108
Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication Fidelity
Smith, E. C., & Denison, M. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003760 · Cited by 109
From SARS coronavirus to novel animal and human coronaviruses.
To, K. K., Hung, I. F., Chan, J. F., & Yuen, K. (2013) · Europe PMC (PubMed Central) · doi:10.3978/asvide.2014.121 · Cited by 107
Hansen, C. B., Jarlhelt, I., Pérez‐Alós, L., Landsy, L. H., Loftager, M., Rosbjerg, A., Helgstrand, C., Bjelke, J. R., Egebjerg, T., Jardine, J. G., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000898 · Cited by 116
Olbei, M. L., Hautefort, I., Módos, D., Treveil, A., Poletti, M., Gul, L., Shannon-Lowe, C. D., & Korcsmáros, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629193 · Cited by 120
Cennamo, N., D’Agostino, G., Perri, C., Arcadio, F., Chiaretti, G., Parisio, E. M., Camarlinghi, G., Vettori, C., Marzo, F. D., Cennamo, R., et al. (2021) · Sensors · doi:10.3390/s21051681 · Cited by 115
Hu, D., Lou, X., Xu, Z., Meng, N., Xie, Q., Zhang, M., Zou, Y., Liu, J., Sun, G., & Wang, F. (2020) · Journal of Global Health · doi:10.7189/jogh.10.0101003 · Cited by 107
Detection of influenza A(H1N1)v virus by real-time RT-PCR
Panning, M., Eickmann, M., Landt, O., Monazahian, M., Ölschläger, S., Baumgarte, S., Reischl, U., Wenzel, J. J., Niller, H. H., Günther, S., et al. (2009) · Eurosurveillance · doi:10.2807/ese.14.36.19329-en · Cited by 108
Self-citationZhu, J., Xiao, G., Xu, Y., Yuan, F., Zheng, C., Liu, Y., Yan, H., Cole, D. K., Bell, J. I., Rao, Z., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.141 · Cited by 110
Bechill, J., Chen, Z., Brewer, J. W., & Baker, S. C. (2008) · Journal of Virology · doi:10.1128/jvi.00017-08 · Cited by 105
Severe acute respiratory syndrome (SARS) in neonates and children
Li, A. M., & Ng, P. C. (2005) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2005.075309 · Cited by 116
Pillaiyar, T., Konno, S., Yamamoto, T., Koiwai, Y., Taguchi, A., Takayama, K., Yakushiji, F., Akaji, K., Chen, S.-E., Naser‐Tavakolian, A., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.07.037 · Cited by 106
Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
Słomka, A., Kowalewski, M., & Żekanowska, E. (2020) · Pathogens · doi:10.3390/pathogens9060493 · Cited by 118
The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak
Lauxmann, M. A., Santucci, N. E., & Autrán-Gómez, A. M. (2020) · International braz j urol · doi:10.1590/s1677-5538.ibju.2020.s101 · Cited by 129
Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I. S., Farouk, A., Song, Y. G., & Dong, J.-J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238344 · Cited by 106
Chen, C. Z., Xu, M., Pradhan, M., Gorshkov, K., Petersen, J. D., Straus, M. R., Zhu, W., Shinn, P., Guo, H., Shen, M., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00112 · Cited by 109
Prill, M. M., Iwane, M. K., Edwards, K. M., Williams, J. V., Weinberg, G. A., Staat, M. A., Willby, M. J., Talbot, H. K., Hall, C. B., Szilagyi, P. G., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31823e07fe · Cited by 105
Covid-19, Coronavirus, SARS-CoV-2 and the small bowel
M�nkemüller, K., Fry, L. C., & Rickes, S. (2020) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2020.7137/2020 · Cited by 121
Guo, H., Hu, B.-J., Yang, X.-L., Zeng, L.-P., Li, B., Ouyang, S., & Shi, Z.-L. (2020) · Journal of Virology · doi:10.1128/jvi.00902-20 · Cited by 108
COVID-19, cytokines, inflammation, and spices: How are they related?
Kunnumakkara, A. B., Rana, V., Parama, D., Banik, K., Girisa, S., Henamayee, S., Thakur, K. K., Dutta, U., Garodia, P., Gupta, S. C., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119201 · Cited by 121
Emerging Viruses in Transplantation: There Is More to Infection After Transplant Than CMV and EBV
Fischer, S. A. (2008) · Transplantation · doi:10.1097/tp.0b013e31818b6548 · Cited by 114
New respiratory viral infections
Jartti, T. T., Jartti, L., Ruuskanen, O., & Söderlund‐Venermo, M. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328351f8d4 · Cited by 123
Nie, Y., Wang, P., Shi, X., Wang, G., Chen, J., Zheng, A., Wang, W., Wang, Z., Qu, X., Luo, M., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.060 · Cited by 107
Zhou, B., Liu, J., Wang, Q., Liu, X. E., Li, X., Li, P., Ma, Q., & Cao, C. (2008) · Journal of Virology · doi:10.1128/jvi.00133-08 · Cited by 113
Is there an ideal animal model for SARS?
Subbarao, K., & Roberts, A. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.05.007 · Cited by 104
Serologic and Molecular Biologic Methods for SARS-associated Coronavirus Infection, Taiwan
Wu, H.-S., Chiu, S., Tseng, T.-C., Lin, S.-F., Lin, J., Hsu, Y.-F., Wang, M.-C., Lin, T., Yang, W., Ferng, T.-L., et al. (2004) · Emerging infectious diseases · doi:10.3201/eid1002.030731 · Cited by 109
Coronavirus cis-Acting RNA Elements
Madhugiri, R., Fricke, M., Marz, M., & Ziebuhr, J. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.007 · Cited by 113
IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
Abbas, A. T., El-Kafrawy, S. A., Sohrab, S. S., & Azhar, E. I. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1514224 · Cited by 114
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome
Crooke, S. N., Ovsyannikova, I. G., Kennedy, R. B., & Poland, G. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70864-8 · Cited by 113
The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2
Chow, R. D., Majety, M., & Chen, S. (2021) · Nature Communications · doi:10.1038/s41467-020-20323-9 · Cited by 108
Cavallazzi, R., & Ramírez, J. A. (2018) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2018.07.005 · Cited by 110
Araújo, D. B., Machado, R. R. G., Amgarten, D., Malta, F. D. M., de Araujo, G. G., Monteiro, C. O., Candido, E. D., Soares, C. P., de Menezes, F. G., Pires, A. C. C., et al. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200342 · Cited by 103
Escutenaire, S., Mohamed, N., Isaksson, M., Thorén, P., Klingeborn, B., Belák, S., Berg, M., & Blomberg, J. (2006) · Archives of Virology · doi:10.1007/s00705-006-0840-x · Cited by 103
Ghosh, A. K., Xi, K., Grum-Tokars, V. L., Xu, X., Ratia, K. M., Fu, W., Houser, K. V., Baker, S. C., Johnson, M. E., & Mesecar, A. D. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.08.031 · Cited by 102
Discovery of Potent Anilide Inhibitors against the Severe Acute Respiratory Syndrome 3CL Protease
Shie, J., Fang, J., Kuo, C., Kuo, T., Liang, P., Huang, H., Yang, W., Lin, C., Chen, J.-L., Wu, Y.-T., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050184y · Cited by 102
Prophylactic and Therapeutic Effects of Small Interfering Rna Targeting Sars-Coronavirus
Zheng, B., Guan, Y., Tang, Q., Cheng, D., Xie, F. Y., He, M., Chan, K.-W., Wong, K., Lader, E., Woodle, M. C., et al. (2004) · Antiviral Therapy · doi:10.1177/135965350400900310 · Cited by 108
Molecular Biology of the SARS-Coronavirus
Lal, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-642-03683-5 · Cited by 103
Friedman, N., Alter, H., Hindiyeh, M., Mendelson, E., Shemer Avni, Y., & Mandelboim, M. (2018) · Viruses · doi:10.3390/v10100515 · Cited by 104
COVID-19 pandemic in resource-poor countries: challenges, experiences and opportunities in Ghana
Afriyie, D. K., Asare, G. A., Amponsah, S. K., & Godman, B. (2020) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.12909 · Cited by 102
Cortes, A. A., & Zuñiga, J. M. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115176 · Cited by 105
Chen, W.-H., Tao, X., Agrawal, A. S., Algaissi, A., Peng, B.-H., Pollet, J., Strych, U., Bottazzi, M. E., Hotez, P. J., Lustigman, S., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.09.061 · Cited by 103
Munekawa, C., Hosomi, Y., Hashimoto, Y., Okamura, T., Takahashi, F., Kawano, R., Nakajima, H., Osaka, T., Okada, H., Majima, S., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0426 · Cited by 115
The Inflammasome in Times of COVID-19
Vaccari, J. C. D. R., Dietrich, W. D., Keane, R. W., & Vaccari, J. P. D. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583373 · Cited by 110
COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Martínez-Salazar, B., Holwerda, M., Stüdle, C., Piragyte, I., Mercader, N., Engelhardt, B., Rieben, R., & Döring, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824851 · Cited by 113
Jain, R. P., Pettersson, H. I., Zhang, J., Aull, K. H., Fortin, P. D., Huitema, C., Eltis, L. D., Parrish, J. C., James, M. N. G., Wishart, D. S., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0494873 · Cited by 102
Detection of alpha and betacoronaviruses in multiple Iberian bat species
Falcón, A. M., Vázquez‐Morón, S., Casas, I., Aznar, C., Carrascoso, G. R., Pozo, F., Pérez‐Breña, P., Javier Juste, B., Ibáñez, C., Garin, I., et al. (2011) · Archives of Virology · doi:10.1007/s00705-011-1057-1 · Cited by 112
Ho, A. S., Sung, J. J. Y., & Chan-Yeung, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-7-200310070-00008 · Cited by 103
The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase
Wei, P., Fan, K., Chen, H., Ma, L., Huang, C., Tan, L., Xi, D., Li, C., Liu, Y., Cao, A., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.102 · Cited by 101
Metadata
- Authors
- Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A.-M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Müller, S., Rickerts, V., Stürmer, M., Vieth, S., Klenk, H.-D., Osterhaus, A. D. M. E., Schmitz, H., & Doerr, H. W.
- Affiliations
- Goethe University Frankfurt (DE)
- From the Bernhard Nocht Institute for Tropical Medicine, National Reference Center for Tropical Infectious Diseases, Hamburg (C.D., S.G., M.P., K.G., S.K., S.M., S.V., H.S.); the Institute of Medical Virology (W.P., H.R., A.B., J.C., M.S., H.W.D.) and the Medical Clinic III (H.-R.B., V.R.), Johann Wolfgang Goethe University, Frankfurt am Main; and the Institute of Virology, Philipps University, Marburg (S.B., L.K., M.E., H.-D.K.) — all in Germany; the Pasteur Institute, Molecular Genetics of Respiratory...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-15
- Volume
- 348
- Issue
- 20
- Pages
- 1967-1976
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132260239
- Semantic Scholar
- 79116f5bb552a1a23de85d03899ab0b3763c81ee
- Cited by
- 4,574
- References
- 10
- Citations by year
- 2026: 40 · 2025: 91 · 2024: 141 · 2023: 193 · 2022: 361 · 2021: 646 · 2020: 913 · 2019: 50 · 2018: 45 · 2017: 49 · 2016: 60 · 2015: 65 · 2014: 91 · 2013: 83 · 2012: 93
- FWCI
- 222.93
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, novel coronavirus, SARS-CoV, virus identification, viral RNA detection, seroconversion, fecal viral shedding, plasma viral RNA
- MeSH terms
- Adult, Amino Acid Sequence, Animals, Base Sequence, Cattle, Disease Outbreaks, DNA, Viral, Female, Humans, Male, Molecular Sequence Data, Phylogeny, RNA, Viral, Sequence Homology, Nucleic Acid, Sputum, Polymerase Chain Reaction, Coronavirus, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.